Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus

Scandinavian Journal of Immunology

Volumn 65, Issue 6, 2007, Pages 494-502

  Istrate, C ^a,b,c   Douagi, I ^b   Charpilienne, A ^d   McInerney, G M ^b   Hidmark, A ^b   Johansen, K ^b   Larsson, M ^c   Magnusson, K E ^c   Poncet, D ^d   Svensson, L ^c   Hinkula, J ^b,c  

^a INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INTERNALIZATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; RHESUS MONKEY; ROTAVIRUS; UPREGULATION; VIRUS ACTIVATION; VIRUS CULTURE; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD86; BONE MARROW CELLS; CATTLE; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GLYCOPROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; TOXINS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRAL NONSTRUCTURAL PROTEINS; VIRION; VIRUS INTERNALIZATION;

EID: 34249326941     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01907.x     Document Type: Article

References (36)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003 9 : 565 72.
2. Parashar UD Glass RI. Public health. Progress toward rotavirus vaccines. Science 2006 312 : 851 2.
3. Brown KA, Offit PA. Rotavirus-specific proteins are detected in murine macrophages in both intestinal and extraintestinal lymphoid tissues. Microb Pathog 1998 24 : 327 31.
4. Dharakul T, Riepenhoff-Talty M, Albini B, Ogra PL. Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol 1988 74 : 14 9.
5. Fleeton MN, Contractor N, Leon F, Wetzel JD, Dermody TS, Kelsall BL. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J Exp Med 2004 200 : 235 45.
6. Larsson M, Beignon AS, Bhardwaj N. DC-virus interplay: a double edged sword. Semin Immunol 2004 16 : 147 61.
7. Sesta K, McNeal MM, Choi A et al. Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol 2004 78 : 10258 64.
8. Narvaez CF, Angel J, Franco MA. Interaction of rotavirus with human myeloid dendritic cells. J Virol 2005 79 : 14526 35.
9. Madore HP, Estes MK, Zarley CD et al. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine. Vaccine 1999 17 : 2461 71.
10. Crawford SE, Labbe M, Cohen J, Burroughs MH, Zhou YJ, Estes MK. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 1994 68 : 5945 52.
11. Crawford SE, Estes MK, Ciarlet M et al. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol 1999 73 : 4813 22.
12. Ciarlet M, Crawford SE, Barone C et al. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol 1998 72 : 9233 46.
13. McNeal MM, Rae MN, Conner ME, Ward RI. Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21. Virology 1998 243 : 158 66.
14. Bertolotti-Ciarlet A, Ciarlet M, Crawford SE, Conner ME, Estes MK. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 2003 21 : 3885 900.
15. Fernandez FM, Conner ME, Parwani AV et al. Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP). Vaccine 1996 14 : 1303 12.
16. Charpilienne A, Nejmeddine M, Berois M et al. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. J Biol Chem 2001 276 : 29361 7.
17. Johansen K, Schroder U, Svensson L. Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants. Vaccine 2003 21 : 368 75.
18. Offit PA, Clark HF, Stroop WG, Twist EM, Plotkin SA. The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods 1983 7 : 29 40.
19. Labbe M, Baudoux P, Charpilienne A, Poncet D, Cohen J. Identification of the nucleic acid binding domain of the rotavirus VP2 protein. J Gen Virol 1994 75 : 3423 30.
20. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992 176 : 1693 702.
21. Crawford S, Mukherjee SK, Estes MK et al. Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol 2001 76 : 6052 61.
22. Ruggeri FM, Greenberg HB. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 1991 65 : 2211 9.
23. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
24. Lopez CB, Yount JS, Moran TM. Toll-like receptor-independent triggering of dendritic cell maturation by viruses. J Virol 2006 80 : 3128 34.
25. Pollara G, Kwan A, Newton PJ, Handley ME, Chain BM, Katz DR. Dendritic cells in viral pathogenesis: protective or defective Int J Exp Pathol 2005 86 : 187 204.
26. Steinman RM. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 2001 68 : 160 6.
27. Briere F, Bendriss-Vermare N, Delale T et al. Origin and filiation of human plasmacytoid dendritic cells. Hum Immunol 2002 63 : 1081 93.
28. Haeryfar SM. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation Trends Immunol 2005 266 : 311 7.
29. Barchet W, Cella M, Colonna M. Plasmacytoid dendritic cells - virus experts of innate immunity. Semin Immunol 2005 17 : 253 61.
30. Lundgren O, Svensson L. Pathogenesis of rotavirus diarrhea. Microbes Infect 2001 3 : 1145 56.
31. Blutt S, Kirkwood CD, Parreno V et al. Rotavirus antigenaemia and viraemia: a common event Lancet 2003 362 : 1445 9.
32. Warfield KI, Bosio CM, Welcher BC et al. Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A 2003 100 : 15889 94.
33. Ye J, Lin J, Sun Y et al. Yang, Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology 2006 351 : 260 70.
34. Zhang R, Li M, Chen C, Yao Q. SHIV virus-like particles bind and activate human dendritic cells. Vaccine 2004 23 : 139 47.
35. Yang R, Wheeler CM, Chen X et al. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J Virol 2005 79 : 6741 50.
36. Yang R, Murillo FM, Cui H et al. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol 2004 78 : 11152 60.